Our top pick for
Beginners
Addex Therapeutics Ltd is a biotechnology business based in the US. Addex Therapeutics shares (ADXN) are listed on the NASDAQ and all prices are listed in US Dollars. Addex Therapeutics employs 26 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Addex Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADXN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Addex Therapeutics stock price (NASDAQ: ADXN)
Use our graph to track the performance of ADXN stocks over time.Addex Therapeutics shares at a glance
Information last updated 2022-06-25.
| Latest market close | $1.05 |
|---|---|
| 52-week range | $1.05 - $10.90 |
| 50-day moving average | $3.83 |
| 200-day moving average | $6.02 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.26 |
Buy Addex Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Addex Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Addex Therapeutics price performance over time
Historical closes compared with the close of $1.05 from 2022-06-28
| 1 week (2022-06-22) | -5.15% |
|---|---|
| 1 month (2022-05-27) | -71.47% |
| 3 months (2022-03-29) | -78.06% |
| 6 months (2021-12-29) | -83.62% |
| 1 year (2021-06-29) | -89.59% |
|---|---|
| 2 years (2020-06-29) | -88.33% |
| 3 years (2019-06-25) | N/A |
| 5 years (2017-06-25) | N/A |
Addex Therapeutics financials
| Revenue TTM | $2.5 million |
|---|---|
| Gross profit TTM | $-9,687,235 |
| Return on assets TTM | -50.84% |
| Return on equity TTM | -110.16% |
| Profit margin | 0% |
| Book value | $2.05 |
| Market capitalisation | $7.4 million |
TTM: trailing 12 months
Addex Therapeutics share dividends
We're not expecting Addex Therapeutics to pay a dividend over the next 12 months.
Addex Therapeutics share price volatility
Over the last 12 months, Addex Therapeutics's shares have ranged in value from as little as $1.05 up to $10.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addex Therapeutics's is 1.3249. This would suggest that Addex Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Addex Therapeutics overview
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. ; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Frequently asked questions
What percentage of Addex Therapeutics is owned by institutions?Currently 16.895% of Addex Therapeutics shares are held by institutions. How many people work for Addex Therapeutics?
Latest data suggests 26 work at Addex Therapeutics. When does the fiscal year end for Addex Therapeutics?
Addex Therapeutics's fiscal year ends in December. Where is Addex Therapeutics based?
Addex Therapeutics's address is: Chemin des Mines, 9, Geneva, Switzerland, 1202 What is Addex Therapeutics's ISIN number?
Addex Therapeutics's international securities identification number is: US00654J1079 What is Addex Therapeutics's CUSIP number?
Addex Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00654J107
More guides on Finder
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
-
How to buy NYIAX (NYX) stock when it goes public
Everything we know about the NYIAX IPO, plus information on how to buy in.
-
How to buy Adamas One Corp (JEWL) stock when it goes public
Everything we know about the Adamas One Corp IPO, plus information on how to buy in.
-
How to buy Glucose Health (GLUC) stock when it goes public
Everything we know about the Glucose Health IPO, plus information on how to buy in.
-
How to buy Boustead Wavefront (BOUW) stock when it goes public
Everything we know about the Boustead Wavefront IPO, plus information on how to buy in.
-
How to buy ParaZero Technologies (PRZO) stock when it goes public
Everything we know about the ParaZero Technologies IPO, plus information on how to buy in.
Ask an Expert